Empareg: Empagliflozin Can Add 4 Years To Life Expectancy In Diabetes With Cvd | Latest News RSS feed

Empareg: Empagliflozin Can Add 4 Years To Life Expectancy In Diabetes With Cvd - Latest News


EMPA-REG: Empagliflozin can add 4 years to life expectancy in diabetes with CVD

Adults with type 2 diabetes and established cardiovascular disease who take the SGLT2 inhibitor empagliflozin can ... or 80 years, we believe that empagliflozin would produce a 12% to 15% increase in ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us